Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Standard Biotools (LAB) Inventory (2016 - 2026)

Standard Biotools has reported Inventory over the past 16 years, most recently at $20.0 million for Q4 2025.

  • Quarterly Inventory fell 3.68% to $20.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $20.0 million through Dec 2025, down 3.68% year-over-year, with the annual reading at $20.0 million for FY2025, 3.68% down from the prior year.
  • Inventory was $20.0 million for Q4 2025 at Standard Biotools, down from $25.4 million in the prior quarter.
  • Over five years, Inventory peaked at $42.6 million in Q3 2024 and troughed at $20.0 million in Q4 2025.
  • The 5-year median for Inventory is $23.0 million (2022), against an average of $26.9 million.
  • Year-over-year, Inventory skyrocketed 94.48% in 2024 and then crashed 43.29% in 2025.
  • A 5-year view of Inventory shows it stood at $20.8 million in 2021, then soared by 58.73% to $33.1 million in 2022, then plummeted by 37.25% to $20.7 million in 2023, then changed by 0.0% to $20.7 million in 2024, then decreased by 3.68% to $20.0 million in 2025.
  • Per Business Quant, the three most recent readings for LAB's Inventory are $20.0 million (Q4 2025), $25.4 million (Q3 2025), and $24.2 million (Q2 2025).